MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Ji-Seon | - |
dc.contributor.author | Nam, Myung-Hyun | - |
dc.contributor.author | Yoon, Soo-Young | - |
dc.contributor.author | Kang, Seong-Ho | - |
dc.date.accessioned | 2021-09-04T14:26:32Z | - |
dc.date.available | 2021-09-04T14:26:32Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2015-07 | - |
dc.identifier.issn | 0145-2126 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/93075 | - |
dc.description.abstract | Trisomy 8 and trisomy 1q are the most frequent chromosomal abnormalities in Korean patients with myelodysplastic syndrome (MDS). MicroRNA (miRNA) deregulation is involved in the development of hematological malignancies, including MDS, and cancer-associated genomic regions are known to encode miRNAs. The aim of the present study was to investigate the involvement of miRNAs encoded by chromosomes 8 and 1q in MDS. For this, the expression of nine miRNAs encoded by chromosome 8 (miR-30b-5p, miR-30d-5p, miR-101-3p, miR-124-3p, miR-151a-5p, miR-320a, miR-486-5p, miR-596, and miR-875-5p) and three miRNAs encoded by chromosome 1 q (miR-29c-3p, miR-194-5p, and miR-214-3p) was compared between 65 MDS patients and 11 controls. We found a significant upregulation of miR-194-5p (5.1-fold, P = 0.002) and miR-320a (2.94-fold, P = 0.016) in MDS patients compared with controls. The patients with low miR-194-5p expression showed a significantly decreased overall survival (P = 0.049). The areas under the miR-194-5p and miR-320a ROC curves were 0.797 (P=0.002) and 0.729 (P= 0.016), respectively. Although these findings need to be validated in a larger patient population, our results indicate that miR-194-5p is a candidate diagnostic biomarker for MDS and that low miR-194-5p expression could be associated with poor overall survival for MDS patients. (C) 2015 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | IDENTIFICATION | - |
dc.subject | CELLS | - |
dc.title | MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Ji-Seon | - |
dc.contributor.affiliatedAuthor | Nam, Myung-Hyun | - |
dc.contributor.affiliatedAuthor | Yoon, Soo-Young | - |
dc.identifier.doi | 10.1016/j.leukres.2015.04.013 | - |
dc.identifier.scopusid | 2-s2.0-84930377843 | - |
dc.identifier.wosid | 000355636700013 | - |
dc.identifier.bibliographicCitation | LEUKEMIA RESEARCH, v.39, no.7, pp.763 - 768 | - |
dc.relation.isPartOf | LEUKEMIA RESEARCH | - |
dc.citation.title | LEUKEMIA RESEARCH | - |
dc.citation.volume | 39 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 763 | - |
dc.citation.endPage | 768 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordAuthor | MDS | - |
dc.subject.keywordAuthor | microRNA | - |
dc.subject.keywordAuthor | Deregulation | - |
dc.subject.keywordAuthor | Diagnosis | - |
dc.subject.keywordAuthor | Prognosis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.